Two nuclear proteins, Cin5 and Ydr259c, confer resistance to cisplatin in Saccharomyces cerevisiae

被引:49
作者
Furuchi, T
Ishikawa, H
Miura, N
Ishizuka, M
Kajiya, K
Kuge, S
Naganuma, A [1 ]
机构
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Biochem Toxicol, Sendai, Miyagi 9808578, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Microbiol, Bunkyo Ku, Tokyo, Japan
关键词
D O I
10.1124/mol.59.3.470
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In an attempt to identify genes that can confer resistance to cisplatin, we introduced a yeast genomic library into Saccharomyces cerevisiae and selected for transformants that grew in the presence of a normally toxic concentration of cisplatin. Plasmids were rescued from the transformants and were analyzed for the presence of individual open reading frames that conferred resistance to cisplatin. We isolated two genes, CIN5 and YDR259c, that increased resistance to cisplatin when overexpressed in Saccharomyces cerevisiae. These genes encoded two proteins, Cin5 and Ydr259c, that were homologous to yAP-1, a basic leucine zipper transcriptional factor that is known to mediate cellular resistance to various toxic agents. The two proteins exhibited stronger homology to each other (33.2% identity, 49.2% similarity) than to all other gene products in S. cerevisiae. Overexpression of each of these proteins also conferred resistance to two DNA-alkylating agents, methylmethanesulfonate and mitomycin C. An experiment with fusion proteins with green fluorescent protein revealed that Cin5 and Ydr259c were localized constitutively in the nuclei of yeast cells. Our results suggest that Cin5 and Ydr259c might be involved in pleiotropic drug-resistance and might protect yeast against the toxicity of cisplatin and other alkylating agents via a single mechanism. These two nuclear proteins might act as transcriptional factors, regulating the expression of certain genes that confer resistance to DNA-alkylating agents.
引用
收藏
页码:470 / 474
页数:5
相关论文
共 24 条
[1]   Inventory and function of yeast ABC proteins: about sex, stress, pleiotropic drug and heavy metal resistance [J].
Bauer, BE ;
Wolfger, H ;
Kuchler, K .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :217-236
[2]  
CHU G, 1994, J BIOL CHEM, V269, P787
[3]  
Dabholkar M, 1996, Cancer Chemother Biol Response Modif, V16, P88
[4]   Identification of Saccharomyces cerevisiae genes conferring resistance to quinoline ring-containing antimalarial drugs [J].
Delling, U ;
Raymond, M ;
Schurr, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1034-1041
[5]   Yap, a novel family of eight bZIP proteins in Saccharomyces cerevisiae with distinct biological functions [J].
Fernandes, L ;
RodriguesPousada, C ;
Struhl, K .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (12) :6982-6993
[6]   ACTIVE EFFLUX SYSTEM FOR CISPLATIN IN CISPLATIN-RESISTANT HUMAN KB CELLS [J].
FUJII, R ;
MUTOH, M ;
NIWA, K ;
YAMADA, K ;
AIKOU, T ;
NAKAGAWA, M ;
KUWANO, M ;
AKIYAMA, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (04) :426-433
[7]   IMPROVED METHOD FOR HIGH-EFFICIENCY TRANSFORMATION OF INTACT YEAST-CELLS [J].
GIETZ, D ;
STJEAN, A ;
WOODS, RA ;
SCHIESTL, RH .
NUCLEIC ACIDS RESEARCH, 1992, 20 (06) :1425-1425
[8]   HIGH-RESISTANCE TO CISPLATIN IN HUMAN OVARIAN-CANCER CELL-LINES IS ASSOCIATED WITH MARKED INCREASE OF GLUTATHIONE SYNTHESIS [J].
GODWIN, AK ;
MEISTER, A ;
ODWYER, PJ ;
HUANG, CS ;
HAMILTON, TC ;
ANDERSON, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :3070-3074
[9]  
Gosland M, 1996, PHARMACOTHERAPY, V16, P16
[10]  
HOFFMAN CS, 1993, CURRENT PROTOCOLS MO